UnitedHealth Group (UNH) is the worst Dow Jones stock Thursday, putting pressure on the price-weighted index, after the health insurance company reported mixed results for its fourth quarter.
In the three months ending December 31, UnitedHealth's revenue increased 6.8% year over year to $100.8 billion, thanks in part to a 4.4% rise in premiums to $76.5 billion. Its earnings per share (EPS) were up 10.6% from the year-ago period to $6.81.
"The people of UnitedHealth Group remain focused on making high-quality, affordable healthcare more available to more people while making the health system easier to navigate for patients and providers, positioning us well for growth in 2025," said UnitedHealth CEO Andrew Witty in a statement.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
While the company's earnings topped the $6.72 per share that Wall Street was anticipating, UNH's revenue fell short of the $101.8 billion analysts called for, according to CNBC. This marks the first top-line miss for UnitedHealth since Q2 2020. Revenue from premiums also came in below expectations of $78.1 billion.
Additionally, UnitedHealth reaffirmed the 2025 outlook it provided last month, which calls for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.
Is UnitedHealth stock a buy, sell or hold?
UnitedHealth has underperformed the broad market over the past 12 months, up 6% on a total return basis (price change plus dividends) vs the S&P 500's 26% gain. But Wall Street remains overwhelmingly bullish on the blue chip stock.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $639.16, representing implied upside of more than 20% to current levels. Additionally, the consensus recommendation is a Strong Buy.
Financial services firm Oppenheimer has an Outperform rating (equivalent to a Buy) on UNH stock with a $640 price target.
"We believe UNH is well positioned by virtue of its diversification, strong track record, elite management team, and exposure to certain higher growth businesses," wrote Oppenheimer analyst Michael Wiederhorn in a December 5 note.
He adds that UnitedHealth's Optum business "is a nice complement to its core managed care operations and continues to account for a large share of earnings" and its "vertical integration strategy strengthens the company's competitive positioning across many areas of the healthcare landscape."
Related Content
-
Fed's Rate Cuts Could Have Impacts You Might Not AnticipateUnderstanding how lower interest rates could impact your wallet can help you determine the right financial moves to make.
-
Past Performance Is Not Indicative of Your Adviser's ExpertiseMany people find a financial adviser by searching online or asking for referrals from friends or family. This can actually end up costing you big-time.
-
I'm want to give my 3 grandkids $5K each for Christmas.You're comfortably retired and want to give your grandkids a big Christmas check, but their parents are worried they might spend it all. We ask the pros for help.
-
Past Performance Is Not Indicative of Your Financial Adviser's Expertise
Many people find a financial adviser by searching online or asking for referrals from friends or family. This can actually end up costing you big-time.
-
I'm a Financial Planner: If You're Not Doing Roth Conversions, You Need to Read ThisRoth conversions and other Roth strategies can be complex, but don't dismiss these tax planning tools outright. They could really work for you and your heirs.
-
Could Traditional Retirement Expectations Be Killing Us? A Retirement Psychologist Makes the CaseA retirement psychologist makes the case: A fulfilling retirement begins with a blueprint for living, rather than simply the accumulation of a large nest egg.
-
I'm a Financial Adviser: This Is How You Can Adapt to Social Security UncertaintyRather than letting the unknowns make you anxious, focus on building a flexible income strategy that can adapt to possible future Social Security changes.
-
I'm a Financial Planner for Millionaires: Here's How to Give Your Kids Cash Gifts Without Triggering IRS PaperworkMost people can gift large sums without paying tax or filing a return, especially by structuring gifts across two tax years or splitting gifts with a spouse.
-
'Boomer Candy' Investments Might Seem Sweet, But They Can Have a Sour AftertasteProducts such as index annuities, structured notes and buffered ETFs might seem appealing, but sometimes they can rob you of flexibility and trap your capital.
-
AI Stocks Lead Nasdaq's 398-Point Nosedive: Stock Market TodayThe major stock market indexes do not yet reflect the bullish tendencies of sector rotation and broadening participation.
-
Got $100 to Gamble? These Penny Stocks Could Be Worth the RideVolatile penny stocks are high-risk plays with potentially high rewards. If you have $100 you can afford to lose, these three names are worth a look.
